Sanford H. Auerbach, MD
Associate Professor, Neurology
Biography
Dr. Sanford Auerbach completed his undergraduate studies at Cornell University in Ithaca, New York. He earned his medical degree at New York Medical College and completed his medical internship at the University of Michigan Medical Center in Ann Arbor, Michigan. He then moved to the Chobanian and Avedisian School of Medicine where he completed his training in Neurology and went on to complete a fellowship in Behavioral Neurology. After, Dr. Auerbach joined the faculty of the Department of Neurology. For a period of time, he devoted part of his efforts to neurorehabilitation and managed the brain injury unit at Braintree Hospital, in addition to developing a clinical program for Alzheimer’s disease at Boston Medical Center. Dr. Auerbach directed all of his efforts to activities at Boston Medical Center and the School of Medicine. He also developed an interest in sleep medicine and became the director of the Sleep Disorders Center at Boston Medical Center. In recent years, his efforts have been split between Sleep Medicine and Behavioral Neurology with an emphasis on dementia. In addition to his activities in the BU ADC, he has been active in the Dementia project of the Framingham Study and a variety of local and national committees. Dr. Auerbach is a member of the Alzheimer’s Association and has served as a member and recent chair of its Board of Directors. He was involved in administrative management of the department and had served as the interim chair of the Department of Neurology. Dr. Auerbach is an Associate Professor of Neurology and Psychiatry. He is a board certified neurologist and a board certified sleep specialist.
Other Positions
- Associate Professor, Psychiatry, Boston University Chobanian & Avedisian School of Medicine
- Investigator, Framingham Heart Study
- Graduate Faculty (Primary Mentor of Grad Students), Boston University Chobanian & Avedisian School of Medicine, Graduate Medical Sciences
Education
- New York Medical College, MD
- Cornell University, BA
Publications
- Published on 8/9/2024
Gotfried MH, Auerbach SH, Dang-Vu TT, Mishima K, Kumar D, Moline M, Malhotra M. Efficacy and safety of insomnia treatment with lemborexant in older adults: analyses from three clinical trials. Drugs Aging. 2024 Aug 09. PMID: 39120786.
Read at: PubMed - Published on 7/3/2024
Kang M, Li C, Mahajan A, Spat-Lemus J, Durape S, Chen J, Gurnani AS, Devine S, Auerbach SH, Ang TFA, Sherva R, Qiu WQ, Lunetta KL, Au R, Farrer LA, Mez J. Subjective Cognitive Decline Plus and Longitudinal Assessment and Risk for Cognitive Impairment. JAMA Psychiatry. 2024 Jul 03. PMID: 38959008.
Read at: PubMed - Published on 11/20/2023
Camerlingo N, Shaafi Kabiri N, Psaltos DJ, Kelly M, Wicker MK, Messina I, Auerbach SH, Zhang H, Messere A, Isik Karahanoglu F, Santamaria M, Demanuele C, Caouette D, Thomas KC. Monitoring Gait and Physical Activity of Elderly Frail Individuals in Free-Living Environment: A Feasibility Study. Gerontology. 2024; 70(4):439-454. PMID: 37984340.
Read at: PubMed - Published on 10/26/2023
Ferretti MT, Ding H, Au R, Liu C, Devine S, Auerbach S, Mez J, Gurnani A, Liu Y, Santuccione A, Ang TFA. Maximizing utility of neuropsychological measures in sex-specific predictive models of incident Alzheimer's disease in the Framingham Heart Study. Alzheimers Dement. 2024 Feb; 20(2):1112-1122. PMID: 37882354.
Read at: PubMed - Published on 4/12/2023
Dupre AE, Cronin MFM, Schmugge S, Tate S, Wack A, Prescott BR, Li C, Auerbach S, Suchdev K, Al-Faraj A, He W, Cervantes-Arslanian AM, Abdennadher M, Saxena A, Lehan W, Russo M, Pugsley B, Greer D, Shin M, Ong CJ. A machine learning eye movement detection algorithm using electrooculography. Sleep. 2023 Apr 12; 46(4). PMID: 36255119.
Read at: PubMed - Published on 2/10/2023
Yuan J, Liu X, Liu C, Ang AF, Massaro J, Devine SA, Auerbach SH, Blusztajn JK, Au R, Jacques PF. Is dietary choline intake related to dementia and Alzheimer's disease risks? Results from the Framingham Heart Study. Am J Clin Nutr. 2022 Nov; 116(5):1201-1207. PMID: 37208066.
Read at: PubMed - Published on 1/19/2023
Hwang PH, Ang TFA, De Anda-Duran I, Liu X, Liu Y, Gurnani A, Mez J, Auerbach S, Joshi P, Yuan J, Devine S, Au R, Liu C. Examination of potentially modifiable dementia risk factors across the adult life course: The Framingham Heart Study. Alzheimers Dement. 2023 Jul; 19(7):2975-2983. PMID: 36656649.
Read at: PubMed - Published on 8/2/2022
Yuan J, Liu X, Liu C, Ang AFA, Massaro J, Devine SA, Auerbach SH, Blusztajn JK, Au R, Jacques PF. Is dietary choline intake related to dementia and Alzheimer's disease risk: results from the Framingham Heart Study. Am J Clin Nutr. 2022 Aug 02. PMID: 35918258.
Read at: PubMed - Published on 4/15/2022
Yuan J, Au R, Karjadi C, Ang TF, Devine S, Auerbach S, DeCarli C, Libon DJ, Mez J, Lin H. Associations Between the Digital Clock Drawing Test and Brain Volume: Large Community-Based Prospective Cohort (Framingham Heart Study). J Med Internet Res. 2022 Apr 15; 24(4):e34513. PMID: 35436225.
Read at: PubMed - Published on 3/23/2022
Zhang X, Tong T, Chang A, Ang TFA, Tao Q, Auerbach S, Devine S, Qiu WQ, Mez J, Massaro J, Lunetta KL, Au R, Farrer LA. Midlife lipid and glucose levels are associated with Alzheimer's disease. Alzheimers Dement. 2023 Jan; 19(1):181-193. PMID: 35319157.
Read at: PubMed
View 70 more publications: View full profile at BUMC